An association between the nasopharyngeal expression of ACE2 and TMPRSS2 genes and the need for oxygen therapy during COVID-19 was described, underlining the importance of considering a cellular model that not only constitutively expresses the two proteins but also has levels that are the closest to the physiological condition [37]. Here, ACE2 is linked to COVID-19.